insulin aspart 100 [iU] / mL Injection 3 mL (Novolog)
Comprehensive product details for sourcing and verification.
| NDC 11 | 00169-6339-10 |
|---|---|
| Product NDC | 00169-6339 |
| Generic Drug Name | insulin aspart |
| Brand Name | Novolog |
| Manufacturer | Novo Nordisk |
| Strength | 100 [iU] / mL |
| Dosage Form | Injection |
| Drug Type | Intravenous; Subcutaneous |
| Package Quantity | 5 Syringe, Plastic |
| Package Description | 5 SYRINGE, PLASTIC in 1 CARTON (0169-6339-10) / 3 mL in 1 SYRINGE, PLASTIC |
| Active Ingredients | Insulin Aspart |
| Marketing Category | BLA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
insulin aspart 100 [iU] / mL Injection is tracked under NDC 00169-6339-10 and rolls up into product family 00169-6339. Use this page to confirm the exact presentation before moving into related family or manufacturer pathways.
- Package configuration: 5 Syringe, Plastic.
- Manufacturer: Novo Nordisk.
- Dosage form: Injection.
- Family size: 2 active presentations.
Click a tag to refine the catalog view around this exact presentation.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Alternate presentations in this family
These nearby exact-item pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.
Drug Shortage Information
This NDC appeared in documented shortage listings in 2021 and 2023 within available-products sections, a recurring pattern that suggests elevated future supply risk.
Drug Shortage Index family
View Insulin aspart in the Drug Shortage IndexCompare related exact NDC products and family-level shortage context for Insulin aspart.Source: Public FDA drug shortage records accessed through FDA-owned openFDA drug shortages queries.
This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
insulin aspart 100 [iU] / mL Injection 3 mL (Novolog), NDC 00169-6339-10, is a Novo Nordisk 100 [iU] / mL injection presentation packaged as 5 Syringe, Plastic. Historical public shortage information is available for this exact presentation.
NDC search formats
- Canonical NDC 11: 00169-6339-10.
- Digits-only NDC 11: 00169633910.
- Possible 10-digit display format: 0169-6339-10 (0169633910).
Helpful product links
- Search by brand name: Novolog.
- Exact NDC 11: 00169-6339-10.
- Product family NDC: 00169-6339.
- Other package sizes in this family: 1 Syringe, Plastic.
- Compare related presentations: insulin aspart 100 [iU] / mL Injection 3 mL (Novolog).
Related shortage research
If your team is researching the broader shortage picture, the family page groups related exact NDC items, brand variations, and family-level shortage context in one place.